Stephen Brozak
Stock Analyst at WBB Securities
(1.85)
# 1,957
Out of 4,667 analysts
8
Total ratings
100%
Success rate
28.04%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stephen Brozak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CDTX Cidara Therapeutics | Maintains: Strong Buy | $40 | $15.12 | +164.55% | 5 | Apr 25, 2024 | |
| ARCT Arcturus Therapeutics Holdings | Downgrades: Hold | $31 | $16.17 | +91.71% | 2 | Jun 9, 2020 | |
| PATH UiPath | Upgrades: Strong Buy | n/a | $12.87 | - | 1 | Jan 22, 2013 |
Cidara Therapeutics
Apr 25, 2024
Maintains: Strong Buy
Price Target: $40
Current: $15.12
Upside: +164.55%
Arcturus Therapeutics Holdings
Jun 9, 2020
Downgrades: Hold
Price Target: $31
Current: $16.17
Upside: +91.71%
UiPath
Jan 22, 2013
Upgrades: Strong Buy
Price Target: n/a
Current: $12.87
Upside: -